| Closed |
S0425 |
GASTRIC |
5/1/2006 |
1/15/2008 |
9% |
|
|
| Closed |
S0127 |
GASTRIC AND GE JUNCTION |
6/1/2002 |
8/15/2003 |
88% |
|
Published
|
| Closed |
S0701 |
Gastric Cancer Prevention |
6/16/2009 |
6/30/2010 |
100% |
|
Published
|
| Closed |
S9926 |
Gastrointestinal Stromal Tumor |
4/15/2000 |
9/1/2003 |
56% |
|
|
| Closed |
S0033 |
Gastrointestinal Stromal Tumor |
12/15/2000 |
9/1/2001 |
100% |
|
Published
|
| Closed |
S9718 |
Gemcitabine + CDDP in SCLC |
7/1/1998 |
6/15/1999 |
100% |
|
Published
|
| Closed |
S9803 |
Gemcitabine for Relapsed MM |
8/15/1998 |
12/15/1999 |
75% |
|
Published
|
| Closed |
S9802 |
Gemcitabine in Advanced Sarcoma |
5/1/1998 |
3/15/1999 |
100% |
|
Published
|
| Closed |
S0339 |
Gemcitabine/Carboplatin & PS-341/NSCLC |
1/15/2004 |
10/1/2004 |
100% |
|
Published
|
| Closed |
S0119 |
Gemcitabine/Irinotecan Untreated Extensive SCLC |
1/1/2002 |
2/15/2003 |
100% |
|
Published
|
| Open |
S2108CD |
Genomic tumor board study |
8/22/2022 |
|
91% |
|
|
| Closed |
SWOG-9444 |
GI TUMOR REPOSITORY |
4/15/1997 |
9/1/2004 |
|
|
|
| Closed |
S0502 |
GIST Ph III imatinib with or without bevacizumab |
4/15/2008 |
10/1/2009 |
2% |
|
Published
|
| Closed |
S0001 |
Glioblastoma Multiforme/Gliosarcoma |
9/1/2001 |
11/15/2005 |
46% |
|
Published
|
| Closed |
S9908 |
Glutamine for Oral Mucositis |
11/1/2001 |
4/15/2005 |
13% |
|
|
| Closed |
S9812 |
GU/Prostate |
6/15/1999 |
6/1/2001 |
100% |
|
Published
|
| Closed |
S9917 |
GU/Prostate (HGPIN) |
2/1/2000 |
11/1/2006 |
53% |
|
Published
|
| Closed |
S9706 |
HD CTX followed by FLUDARA in B-Cell CLL |
9/15/1997 |
3/1/1999 |
100% |
|
Published
|
| Closed |
SWOG-7969 |
Hepatic Infusion and Systemic Combination Chemotherapy in the Treatment of Unresectable Hepatoma |
10/18/1979 |
3/30/1983 |
|
|
|
| Closed |
SWOG-7904 |
Hexamethylmelamine vs FAC in Advanced Transitional Cell Bladder Carcinoma in Patients with Impaired Renal Function |
4/17/1979 |
9/10/1982 |
|
|
|
